Purification of HER-2 variants

Details for Australian Patent Application No. 2004249362 (hide)

Owner BN ImmunoTherapeutics, Inc.

Inventors Eskling, Marie; Nielsen, Klaus Gregorius

Agent Freehills

Pub. Number AU-B-2004249362

PCT Pub. Number WO2004/113377

Priority PA 2003 00954 25.06.03 DK; 60/482,315 25.06.03 US

Filing date 24 June 2004

Wipo publication date 29 December 2004

Acceptance publication date 25 August 2011

International Classifications

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

C07K 14/71 (2006.01) Peptides having more than 20 amino acids

Event Publications

1 December 2005 PCT application entered the National Phase

  PCT publication WO2004/113377 Priority application(s): WO2004/113377

26 November 2009 Assignment before Grant

  Pharmexa A/S The application has been assigned to BN ImmunoTherapeutics, Inc.

25 August 2011 Application Accepted

  Published as AU-B-2004249362

22 December 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004249363-Libraries containing heterocyclic organic molecules prepared through intramolecular formation of N-acyliminium ions

2004249345-Novel crystalline forms of perindopril erbumine